. . "Patients treated during childhood for malignancy with cardiotoxical anthracycline treatment are risk group for development of cardiovascular diseases in adulthood. Frequence of anthracycline cardiotoxicity is connected with total dose of anthracyclines. Heart complication increace in relation to time after endindg of treatment. Following od heart functions with exrcise echocardiography and spiroergography can show up pathological symptoms. For development of cardiovascular functions it is necessary sensitivity of baroreflex and monitoring of blood pressure. Very importand is following of sport activity and nutrition. Correlation of all methods can showes possible changes and come to lowering the risk of cardiovascular diseases in adulthood. These diseases are most frequent case of mortality in our country. Its lowering is prior for Health 21."@en . "2007-08-08+02:00"^^ . " anthracyclines" . "40"^^ . "D\u011Bti l\u00E9\u010Den\u00E9 v d\u011Btstv\u00ED pro zhoubn\u00FD n\u00E1dor kardiotoxickou terapi\u00ED antracykliny p\u0159edstavuj\u00ED rizikovou skupinu pro rozvoj kardiovasul\u00E1rn\u00EDch chorob v dosp\u011Blosti. V\u00FDskyt antracyklinov\u00E9 kardiotoxicity je z\u00E1visl\u00FD na celkov\u00E9 d\u00E1vce antracyklin\u016F. Srde\u010Dn\u00EDch komplikac\u00ED p\u0159ib\u00FDv\u00E1 s d\u00E9lkou od ukon\u010Den\u00E9 terapie. Sledov\u00E1n\u00ED srde\u010Dn\u00EDch funkc\u00ED pomoc\u00ED z\u00E1t\u011B\u017Eov\u00E9 echokardigrafie a spiroergometrie m\u016F\u017Ee odhalit patologii. Pro v\u00FDvoj kardiovaskul\u00E1rn\u00EDch funkc\u00ED je d\u016Fle\u017Eit\u00E9 stanoven\u00ED sensitivity baroreflexu a monitorov\u00E1n\u00ED tlaku krve. D\u016Fle\u017Eit\u00E9 je i sledov\u00E1n\u00ED pohybov\u00E9 aktivity a v\u00FD\u017Eivy. Korelac\u00ED po\u017Eit\u00FDch metod lze odhalit p\u0159\u00EDpadn\u00E9 zm\u011Bny a t\u00EDm p\u0159isp\u011Bt ke sn\u00ED\u017Een\u00ED rizika kardiovakul\u00E1rn\u00EDch chorob v dosp\u011Blosti, kter\u00E9 p\u0159edstavuj\u00ED nej\u010Dast\u011Bj\u0161\u00ED p\u0159\u00ED\u010Dinu \u00FAmrt\u00ED u dosp\u011Bl\u00FDch v na\u0161\u00ED zemi. Jejich sn\u00ED\u017Een\u00ED pat\u0159\u00ED k priorit\u00E1m %22Zdrav\u00ED 21%22." . "40"^^ . " echocardigraphy" . . . . "Autonomn\u00ED ob\u011Bhov\u00E9 funkce, funkce myokardu a kardiorespira\u010Dn\u00ED funkce u d\u011Bt\u00ED a adolescent\u016F po l\u00E9\u010Db\u011B zhoubn\u00E9ho n\u00E1doru" . . . " malignities in childhood" . . . . "http://www.isvav.cz/projectDetail.do?rowId=NR8006"^^ . . . "Autonomic diysfunction without clinical manifestation was proved in adolescents treated by anthracyclines for malignant disease. This fact shows the necessity of their longitudinal examination with the aim starting therapy at early symptoms."@en . . . . " blood pressure" . . "Automonous circulations functions,myocard and cardiorespiratory functions in children and adolescents after malignancy treatment."@en . "youth; malignities in childhood; anthracyclines; cardiotoxicity; echocardigraphy; baroreflex; blood pressure; spiroergometry"@en . "0"^^ . "NR8006" . . . "0"^^ . "youth" . " baroreflex" . "1"^^ . . " cardiotoxicity" . . . "U adolescent\u016F po l\u00E9\u010Db\u011B zhoubn\u00E9ho n\u00E1doru antracykliny byl prok\u00E1z\u00E1no posti\u017Een\u00ED autonomn\u00EDch funkc\u00ED, kter\u00E9 se neprojevilo klinick\u00FDmi p\u0159\u00EDznaky. To ukazuje na nutnost dlouhodob\u00E9ho jejich sledov\u00E1n\u00ED s c\u00EDlem zah\u00E1jit terapii p\u0159i \u010Dasn\u00FDch klinick\u00FDch p\u0159\u00EDznac\u00EDch."@cs .